To Study Generic Tacrolimus Ointment, 0.1% in the Treatment of Moderate to Severe Atopic Dermatitis (Inflammation of Skin: Itchy, Red, Swollen, and Cracked Skin)
Clinical trial NCT02601703 · COMPLETED
Trial details
- NCT number
- NCT02601703
- Sponsor
- Glenmark Pharmaceuticals Ltd. India
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-01
- Primary completion
- 2016-10-01
- Enrollment
- 1110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.